[
 {
  "document": {
   "authors": "Abish K",
   "contact_info": "abish@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "Rodrigues_et.al_2020.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "HGNC",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "TAX",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "COVID",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "GO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "CHEBI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MESH",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Species",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "CellLine",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20190128.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Cell",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20190128.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Assay",
     "type": "LIST",
     "value": null,
     "value_list": [
      "zymographic assay"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Concentration",
     "type": "LIST",
     "value": null,
     "value_list": [
      "1 \u03bcM",
      "10 \u03bcM"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Custom_Disease",
     "type": "LIST",
     "value": null,
     "value_list": [
      "COVID-19"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Custom_CellLine",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Vero E6 cell"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Research"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Preprint"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Results"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "DOI",
       "title": "",
       "ref": "10.1101/2020.04.04.020925v2",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Research"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Preprint"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Results"
       ]
      }
     },
     {
      "evidence": "The more spontaneous binding of ATV, suggested by its lower energy score, may be related to its projected ability to form hydrogens bonds with the amino acid residues Asn142, His164, and Glu166 in Mpro, whereas the binding of LPV depends on hydrophobic interactions (Figure 2)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "atazanavir"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           },
           [
            [
             {
              "function": {
               "type": "modifier",
               "name": "fragment"
              }
             },
             [
              {
               "range": "3264_3569",
               "descriptor": ""
              }
             ]
            ]
           ]
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Hydrogen Bonding"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "In the infected cells, a region of activity was observed between 31 and 38 kDa that was not present in the mock fraction. This zone of molecular weight is consistent with expected size of SARS-CoV-2 Mpro as was the inhibition of activity in this region by exposure of the gels to 10 \u03bcM of ATV, which did not affect the cellular cysteine proteinase at 70 kDa (Figure 5, lanes ATV)."
     },
     {
      "set": {
       "Assay": [
        "zymographic assay"
       ]
      }
     },
     {
      "set": {
       "Concentration": [
        "10 \u03bcM"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "atazanavir"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           },
           [
            [
             {
              "function": {
               "type": "modifier",
               "name": "fragment"
              }
             },
             [
              {
               "range": "3264_3569",
               "descriptor": ""
              }
             ]
            ]
           ]
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "COVID",
           "name": "ORF1ab"
          },
          [
           [
            {
             "function": {
              "type": "modifier",
              "name": "fragment"
             }
            },
            [
             {
              "range": "3264_3569",
              "descriptor": ""
             }
            ]
           ]
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Concentration"
      ]
     },
     {
      "unset": [
       "Assay"
      ]
     },
     {
      "evidence": "Further confirmation of the presence and activity of SARS-CoV-2 Mpro in fractions from infected cells was obtained by treatment with RTV, which inhibited activity in the molecular range of 31-38 kDa without a change in the 70 kDa region (Figure 5, lanes RTV)."
     },
     {
      "set": {
       "Assay": [
        "zymographic assay"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "ritonavir"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           },
           [
            [
             {
              "function": {
               "type": "modifier",
               "name": "fragment"
              }
             },
             [
              {
               "range": "3264_3569",
               "descriptor": ""
              }
             ]
            ]
           ]
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "COVID",
           "name": "ORF1ab"
          },
          [
           [
            {
             "function": {
              "type": "modifier",
              "name": "fragment"
             }
            },
            [
             {
              "range": "3264_3569",
              "descriptor": ""
             }
            ]
           ]
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Assay"
      ]
     },
     {
      "evidence": "ATV alone, or in combination with RTV, inhibited infectious virus production and SARS-CoV RNA levels in Vero cells (Figure 6A and B, respectively)."
     },
     {
      "set": {
       "Custom_CellLine": [
        "Vero E6 cell"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "atazanavir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "atazanavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "ritonavir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "RNA viral genome"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "atazanavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "RNA viral genome"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "RNA viral genome"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "evidence": "ATV alone showed a nearly 10-fold increase in potency for inhibiting SARS-CoV-2 replication in A549 (Figure 6C) compared to Vero cells (Figure 6B). ATV/RTV and CQ were similarly potent in inhibiting virus replication in both cell types (Figure 6B and C)."
     },
     {
      "set": {
       "CellLine": [
        "A549 cell"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "ritonavir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Virus Replication"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "set": {
       "Custom_CellLine": [
        "Vero E6 cell"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "atazanavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Virus Replication"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "chloroquine"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Virus Replication"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Virus Replication"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_CellLine"
      ]
     },
     {
      "unset": [
       "CellLine"
      ]
     },
     {
      "evidence": "ATV/RTV and CQ were similarly efficient to inhibit viral replication in the human monocytes (Figure 7A)."
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     },
     {
      "set": {
       "Cell": [
        "monocyte"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "atazanavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Virus Replication"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "chloroquine"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Virus Replication"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Cell"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     },
     {
      "evidence": "Moreover, we observed that infections by SARS-CoV-2 triggered the expected increase in the IL-6 levels in the culture supernatant, which ranged from 20- to 60-fold depending on the cell donor (Figure 7C, open circles in nil-treated cells). The virus-induced enhancement of IL-6 levels were significantly prevented by treatment with ATV at 10 \u00b5M, ATV/RTV at both 1 and 10 \u00b5M and CQ at 10 \u00b5M (Figure 7C)."
     },
     {
      "set": {
       "Custom_Disease": [
        "COVID-19"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "IL6"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "set": {
       "Concentration": [
        "1 \u03bcM"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "atazanavir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "IL6"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Concentration"
      ]
     },
     {
      "set": {
       "Concentration": [
        "10 \u03bcM"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "chloroquine"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "IL6"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Concentration"
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "atazanavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "IL6"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Another biomarker of uncontrolled pro-inflammatory cytokine response, TNF-\u03b1, was up-regulated 40-fold during virus infection (Figure 7D). Only the combination of ATV/RTV could significantly prevent the induction of TNF-\u03b1 release (Figure 7D)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TNF"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "atazanavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TNF"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_Disease"
      ]
     },
     {
      "unset": [
       "Section"
      ]
     },
     {
      "unset": [
       "PublicationStatus"
      ]
     },
     {
      "unset": [
       "PublicationType"
      ]
     },
     {
      "unset": [
       "Citation"
      ]
     }
    ]
   }
  ]
 }
]